For example,
Trump asks pharmaceutical industry lower:
US President Donald Trump has sent 17 pharmaceutical companies on Thursday to ask them to lower the prices of medicines sold in the United States under penalty of reprisals. Therefore, the White House announced.
“He signed 17 letters to pharmaceutical companies 17 letters. Meanwhile, ” said spokesperson Karoline Leavitt at a press conference, before reading that addressed to the CEO of Eli Lilly, David Ricks.
The account of the Head of State. on his Truth Social platform, has in the process published all the letters, intended for the leaders of Merck, Novartis, Pfizer, Astrazeneca, Novo Nordisk and Sanofi, among others.
“If you refuse to act. we will deploy all the means at our disposal to protect American families against abusive practices in terms of drug prices,” writes the president in these almost identical letters.
He gives them until September 29 trump asks pharmaceutical industry lower to present “firm commitments” in this sense.
On May 12. Donald Trump had announced a plan to considerably reduce the prices of medicines in the United States by lining them over those paid by other major economies, a promise that he had failed to hold during his first mandate.
“The prices of certain prescription drugs. pharmaceutical products will drop almost immediately from 50 to 80 or 90%” for the Americans, “he then proclaimed.
He mainly intended to obtain these spectacular discounts through negotiations with pharmaceutical groups, opposed in the past to price reductions.
Medication prices in the United States are among the highest in the world. surpass those applied to their neighbors and in Europe.
According to a study by the RAND Corporation, Americans pay an average of 2.5 times more for prescription drugs than the French for example. Donald Trump was committed to reducing this gap during his presidential trump asks pharmaceutical industry lower campaign.
On the New York Stock Exchange, the pharmaceutical sector was somewhat heckled by this announcement. Eli Lilly released 1.33%, Merck retreated 3.59%and Novo Nordisk dug his losses (-4.65%).
The Astrazeneca (-3.26%) and Pfizer (-1.42%) laboratories were also shunned.
Trump asks pharmaceutical industry lower
Further reading: Electricity AI: Trump will unveil investments of $ 70 billion – Employment increasing in Canada for the first time since January – Who is this rare land operator bought by the Pentagon? – Japan, Vietnam, United Kingdom: here are the first trade agreements announced so far with the United States – Derivative products sold by UBS are controversial – rts.ch.
